0001104659-20-125389.txt : 20201116 0001104659-20-125389.hdr.sgml : 20201116 20201116072112 ACCESSION NUMBER: 0001104659-20-125389 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20201113 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20201116 DATE AS OF CHANGE: 20201116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Liquidia Technologies Inc CENTRAL INDEX KEY: 0001330436 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38601 FILM NUMBER: 201313660 BUSINESS ADDRESS: STREET 1: 419 DAVIS DRIVE STREET 2: SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-328-4400 MAIL ADDRESS: STREET 1: P.O. BOX 110085 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 8-K 1 tm2035325-3_8k.htm FORM 8-K
0001330436 false 0001330436 2020-11-13 2020-11-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 13, 2020

 

LIQUIDIA TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)

 

Delaware   001-38601   20-1926605
(State or other jurisdiction
of incorporation)		   (Commission
File Number)		   (IRS Employer
Identification No.)

 

     
419 Davis Drive, Suite 100, Morrisville, North Carolina   27560
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (919) 328-4400

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

x Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock LQDA The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

 

 

 

 

 

 

Item 5.07Submission of Matters to a Vote of Security Holders.

 

On November 13, 2020, Liquidia Technologies, Inc., a Delaware corporation (the “Company”), held a special meeting of stockholders (the “Special Meeting”). At the Special Meeting, the following matters were submitted to a vote of stockholders:

 

1.The approval of the Agreement and Plan of Merger, dated as of June 29, 2020, among the Company, RareGen, LLC (“RareGen”), Liquidia Corporation (“HoldCo”), Gemini Merger Sub I, Inc. (“Liquidia Merger Sub”), Gemini Merger Sub II, LLC and PBM RG Holdings, LLC (the “Merger Agreement”), pursuant to which the Company and RareGen will each become a subsidiary of HoldCo, and each share of Company common stock, $0.001 par value per share (“Company Common Stock”), will be automatically converted into one share of HoldCo common stock, $0.001 par value per share (the “Merger Transaction”), and to approve the merger of Liquidia Merger Sub with and into the Company (the “Liquidia Merger”);
2.The approval of the Liquidia Corporation 2020 Long-Term Incentive Plan (the “2020 LTIP”), effective upon completion of the Merger Transaction;
3.The approval of the Liquidia Corporation 2020 Employee Stock Purchase Plan (the “2020 ESPP”), effective upon completion of the Merger Transaction;
4.The ratification of the appointment of PricewaterhouseCoopers LLP as HoldCo’s independent registered public accounting firm for the year ending December 31, 2020; and
5.The approval of the grant of discretionary authority to the board of directors of the Company (the “Company Board”) to adjourn or postpone the Special Meeting to a later date, if necessary, to solicit additional proxies if there are insufficient votes in favor of Proposals 1, 2, 3 or 4.

 

At the close of business on September 14, 2020, the record date for the determination of stockholders entitled to vote at the Special Meeting, there were 37,752,027 shares of Company Common Stock outstanding and entitled to vote at the Special Meeting. The holders of 33,925,968 shares of Company Common Stock were represented virtually or by proxy at the Special Meeting, constituting a quorum.

 

At the Special Meeting, (i) the Merger Agreement and the Liquidia Merger were approved, (ii) the 2020 LTIP was approved, effective upon completion of the Merger Transaction, (iii) the 2020 ESPP was approved, effective upon completion of the Merger Transaction; and (iv) the appointment of HoldCo’s independent registered public accounting firm for the year ending December 31, 2020 was ratified. The closing of the Merger Transaction is expected to occur on or about November 18, 2020, subject to the satisfaction of the closing conditions set forth in the Merger Agreement.

 

Proposal No. 1— Approval of the Merger Agreement and the Liquidia Merger

 

The vote with respect to the Merger Agreement and the Liquidia Merger was as follows:

 

For   Against   Abstain   Broker Non-
Votes		  
26,672,751   1,544,435   242,280   5,466,502  

 

Proposal No. 2 — Approval of the 2020 LTIP

 

The vote with respect to the 2020 LTIP was as follows:

 

For   Against   Abstain   Broker Non-
Votes		  
18,661,608   8,251,256   1,546,602   5,466,502  

 

Proposal No. 3 — Approval of the 2020 ESPP

 

The vote with respect to the 2020 ESPP was as follows:

 

For   Against   Abstain   Broker Non-
Votes		  
24,792,197   2,696,752   970,517   5,466,502  

 

 

 

 

Proposal No. 4 — Ratification of the Appointment of Independent Registered Public Accounting Firm

 

The vote with respect to the ratification of the appointment of PricewaterhouseCoopers LLP as HoldCo’s independent registered public accounting firm for the year ending December 31, 2020 was as follows:

 

For   Against   Abstain  
32,868,858   90,457   966,653  

 

Item 8.01Other Events.

 

On November 16, 2020, the Company issued a press release announcing that its stockholders have approved the Merger Agreement and the Liquidia Merger, in addition to the other proposals described above. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)

 

Exhibit
No.		   Exhibit
99.1   Press Release of Liquidia Technologies, Inc., dated November 16, 2020.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

Cautionary Statements Regarding Forward Looking Statements

 

This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the potential timing or consummation of the proposed Merger Transaction or the anticipated benefits thereof, including, without limitation, future financial and operating results. The Company cautions readers that these and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to risks and uncertainties related to (i) the risk that a condition to closing of the Merger Transaction may not be satisfied, (ii) the ability of the Company and RareGen to integrate their businesses successfully and to achieve anticipated cost savings and other synergies, (iii) the possibility that other anticipated benefits of the proposed Merger Transaction will not be realized, including without limitation, anticipated revenues, expenses, earnings and other financial results, and growth and expansion of the new combined company’s operations, and the anticipated tax treatment, (iv) potential litigation relating to the proposed Merger Transaction that has and could be instituted against the Company, RareGen or their respective officers or directors, (v) possible disruptions from the proposed Merger Transaction that could harm the Company’s or RareGen’s business, including current plans and operations, (vi) the ability of the Company or RareGen to retain, attract and hire key personnel, (vii) potential adverse reactions or changes to relationships with employees, customers, suppliers, licensees, collaborators, business partners or other parties resulting from the announcement or completion of the Merger Transaction, (viii) potential business uncertainty, including changes to existing business relationships, during the pendency of the Merger Transaction that could affect the Company’s and/or RareGen’s financial performance, (ix) certain restrictions during the pendency of the Merger Transaction that may impact the Company’s or RareGen’s ability to pursue certain business opportunities or strategic transactions, (x) continued availability of capital and financing and rating agency actions, (xi) legislative, regulatory and economic developments and (xii) unpredictability and severity of catastrophic events, including, but not limited to, global pandemics such as coronavirus, acts of terrorism or outbreak of war or hostilities, as well as management’s response to any of the aforementioned factors. These risks, as well as other risks associated with the proposed Merger Transaction, as more fully discussed in the proxy statement/prospectus in connection with the proposed Merger Transaction which was declared effective on September 16, 2020, as subsequently supplemented. While the list of factors presented here is, and the list of factors to be presented in the registration statement on Form S-4 are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on the Company’s or RareGen’s consolidated financial condition, results of operations, credit rating or liquidity. Neither the Company nor RareGen assumes any obligation to provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

 

 

 

 

No Offer or Solicitation

 

This communication is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.

 

Important Information About the Transaction and Where to Find It

 

In connection with the proposed Merger Transaction, the Company and HoldCo have filed documents with the  U.S. Securities and Exchange Corporation (the “SEC”), including the filing by HoldCo of a registration statement on Form S-4, which was declared effective on September 16, 2020, and a final proxy statement/prospectus (including the supplements thereto), and the Company mailed a proxy statement regarding the proposed Merger Transaction to its stockholders that also constitutes a prospectus of the Company. This document is not a substitute for the proxy statement/prospectus or registration statement or any other document which the Company or Liquidia Corporation have filed with the SEC. Investors and security holders of the Company and RareGen are urged to read the registration statement, the proxy statement/prospectus and any other relevant documents, as well as any amendments or supplements to these documents, carefully and in their entirety because they will contain important information. Investors and security holders may obtain free copies of the registration statement and the proxy statement/prospectus and other documents filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov or by contacting the investor relations department of the Company  at the following:

 

Liquidia Technologies, Inc.
Jason Adair
Investor Relations
(919) 328-4350
Jason.adair@liquidia.com

 

Participants in the Solicitation

 

The Company, RareGen and certain of their respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed Merger Transaction and related matters. Information regarding the Company’s directors and executive officers, including a description of their direct interests, by security holdings or otherwise, is contained in the Company’s Form 10-K for the year ended December 31, 2019 and its proxy statement filed on April 28, 2020, which are filed with the SEC. Additional information is available in the registration statement on Form S-4 and the proxy statement/prospectus (including the supplements thereto) related to the proposed Merger Transaction. 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

November 16, 2020 Liquidia Technologies, Inc.
   
   
  By: /s/ Steven Bariahtaris
    Name:  Steven Bariahtaris
    Title: Interim Chief Financial Officer

 

 

 EX-99.1 2 tm2035325d3_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

Liquidia Technologies, Inc.

419 Davis Drive, Suite 100

Morrisville, NC 27560

MEDIA RELEASE

www.liquidia.com

 

Liquidia Announces Results of Special Meeting of Stockholders

 

Stockholders Approve RareGen Acquisition

Merger Expected to Close on or About November 18, 2020

 

RESEARCH TRIANGLE PARK, N.C., November 16, 2020 - Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology, today announced that its stockholders voted to adopt and approve the previously announced merger agreement, dated as of June 29, 2020, among the Company, RareGen, LLC (“RareGen”), Liquidia Corporation (“Liquidia Corporation”), Gemini Merger Sub I, Inc. (“Liquidia Merger Sub”), Gemini Merger Sub II, LLC and PBM RG Holdings, LLC (the “Merger Agreement”), including the merger of the Company with and into Liquidia Merger Sub (the “Liquidia Merger”), with the Company and RareGen surviving as wholly owned subsidiaries of Liquidia Corporation post-merger, at a special meeting of stockholders held on November 13, 2020. In addition, Liquidia stockholders voted to approve all other matters related to the Merger Agreement and the Liquidia Merger.

 

At the close of business on September 14, 2020, the record date for the special meeting, there were 37,752,027 shares of Company common stock outstanding. Approximately 71 percent of the shares outstanding as of September 14, 2020 voted to adopt and approve the Merger Agreement. Further, among other proposals, stockholders voted to approve the Liquidia Corporation 2020 Long-Term Incentive Plan and the Liquidia Corporation 2020 Employee Stock Purchase Plan, both of which will be effective upon completion of the merger.

 

The closing of the merger transaction is expected to occur on or about November 18, 2020, subject to the satisfaction of the closing conditions set forth in the Merger Agreement.

 

About Liquidia

 

Liquidia is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. Currently, Liquidia is focused on the development of two product candidates for which it holds worldwide commercial rights: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. Liquidia is headquartered in Research Triangle Park, NC. For more information, please visit www.liquidia.com.

 

 

 

 

 

 

Liquidia Technologies, Inc.

419 Davis Drive, Suite 100

Morrisville, NC 27560

MEDIA RELEASE

www.liquidia.com

 

About RareGen

 

RareGen, LLC is a portfolio company of PBM Capital Group, a healthcare investment firm. RareGen provides strategy, investment, and commercialization for rare disease pharmaceutical products. RareGen has a national sales force focused on cardiology and pulmonology specialties.

 

Important Information About the Transaction and Where to Find It

 

In connection with the proposed merger transaction, the Company and Liquidia Corporation have filed documents with the SEC, including the filing by Liquidia Corporation of a registration statement on Form S-4, which was declared effective on September 16, 2020, and a final proxy statement/prospectus (including the supplements thereto), and the Company mailed a proxy statement (and supplements thereto) regarding the proposed merger transaction to its stockholders that also constitutes a prospectus of the Company. This document is not a substitute for the proxy statement/prospectus or registration statement or any other document which the Company or Liquidia Corporation have filed with the SEC. Investors and security holders of the Company and RareGen are urged to read the registration statement, the proxy statement/prospectus and any other relevant documents, as well as any amendments or supplements to these documents, carefully and in their entirety because they will contain important information. Investors and security holders may obtain free copies of the registration statement and the proxy statement/prospectus and other documents filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov or by contacting the investor relations department of the Company  at the following:

 

Liquidia Technologies, Inc.
Jason Adair
Investor Relations
(919) 328-4350
Jason.adair@liquidia.com

 

Participants in the Solicitation

 

The Company, RareGen and certain of their respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction and related matters. Information regarding the Company’s directors and executive officers, including a description of their direct interests, by security holdings or otherwise, is contained in the Company’s Form 10-K for the year ended December 31, 2019 and its proxy statement filed on April 28, 2020, which are filed with the SEC. Additional information is available in the registration statement on Form S-4 and the proxy statement/prospectus (as supplemented).

 

 

 

 

 

 

Liquidia Technologies, Inc.

419 Davis Drive, Suite 100

Morrisville, NC 27560

MEDIA RELEASE

www.liquidia.com

 

No Offer or Solicitation

 

This communication is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

 

Cautionary Statements Regarding Forward Looking Statements 

 

This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the potential timing or consummation of the proposed merger transaction or the anticipated benefits thereof, including, without limitation, future financial and operating results. The Company cautions readers that these and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to risks and uncertainties related to (i) the risk that a condition to closing of the merger transaction may not be satisfied, (ii) the ability of the Company and RareGen to integrate their businesses successfully and to achieve anticipated cost savings and other synergies, (iii) the possibility that other anticipated benefits of the proposed merger transaction will not be realized, including without limitation, anticipated revenues, expenses, earnings and other financial results, and growth and expansion of the new combined company’s operations, and the anticipated tax treatment, (iv) potential litigation relating to the proposed merger transaction that has and could be instituted against the Company, RareGen or their respective officers or directors, (v) possible disruptions from the proposed merger transaction that could harm the Company’s or RareGen’s business, including current plans and operations, (vi) the ability of the Company or RareGen to retain, attract and hire key personnel, (vii) potential adverse reactions or changes to relationships with employees, customers, suppliers, licensees, collaborators, business partners or other parties resulting from the announcement or completion of the merger transaction, (viii) potential business uncertainty, including changes to existing business relationships, during the pendency of the merger transaction that could affect the Company’s and/or RareGen’s financial performance, (ix) certain restrictions during the pendency of the merger transaction that may impact the Company’s or RareGen’s ability to pursue certain business opportunities or strategic transactions, (x) continued availability of capital and financing and rating agency actions, (xi) legislative, regulatory and economic developments and (xii) unpredictability and severity of catastrophic events, including, but not limited to, global pandemics such as coronavirus, acts of terrorism or outbreak of war or hostilities, as well as management’s response to any of the aforementioned factors. These risks, as well as other risks associated with the proposed merger transaction, as more fully discussed in the proxy statement/prospectus in connection with the proposed merger transaction, which was declared effective on September 16, 2020, as subsequently supplemented. While the list of factors presented here is, and the list of factors to be presented in the registration statement on Form S-4 are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on the Company’s or RareGen’s consolidated financial condition, results of operations, credit rating or liquidity. Neither the Company nor RareGen assumes any obligation to provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

 

 

 

 

 

 

Liquidia Technologies, Inc.

419 Davis Drive, Suite 100

Morrisville, NC 27560

MEDIA RELEASE

www.liquidia.com

 

Contact Information

 

Media:

Michael Parks
Corporate Communications
484.356.7105
michael.parks@liquidia.com

 

Investors:

Jason Adair
Vice President, Corporate Development and Strategy
919.328.4400
jason.adair@liquidia.com

 

 

 EX-101.SCH 3 lqda-20201113.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 lqda-20201113_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 lqda-20201113_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2035325d3_ex99-1img01.jpg GRAPHIC begin 644 tm2035325d3_ex99-1img01.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# (! 0(! 0(" @(" @(" P4# P,# M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_ MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P, M# P,# P,# P,# P,# P,# P,# P,# S_P 1" Q *\# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#]];_4K?2K M8S74\-M"I ,DKA%&>G)XJ2VN8[RW26)TEBD&Y'1MRL/4$=:^)O\ @X8N9+3_ M ()>>+I(I'C<:GI>&1B"/],C[U[1_P $QI&E_P"">/P69F9V;P?IQ+,7:"E?U;5K?(]TJK9:U9ZE<2Q6 M]W;3RP'$J1RJS1GI\P!XZ=ZM5^6G_!#:\FN/^"BW[7J22RR)'KK;%9R0O_$Q MONGI2P66_6,+7Q'-;V23M;>\DOD/&9A[#$T,/RW]HVK]K*_S/U+K@?VA_P!I M_P "?LJ> Y_$?CWQ'I^@:;"I9/.?,UR0,[(HAEY&]E!KPS_@IA^VUXW_ &;= M5\"^"?ASH>G:CXR^)=TUAIUW?2#R;.3?'&N$) 9B9!@L=HQR#TKSWX&?\$9% M\=>.X?B#^TEXHN_BMXP)$J:5+,QTBS;J%9>/-QV7"Q#IL(KYJKC*DJCH8:-Y M+=O9?YOR1^H99PG@J. IYSG]?V=&I=TX0M*K4Y6XNR^&$;IKFF]UI%GTA^R1 M^WK\+_VVO#']H^ O$D%[<1C-SIER/L^H6?\ OPDYQ_M+E?>O8Z^+?VIO^",/ M@OXC^*5\;?"B_F^#WQ%M2)(KS1;#&1L;_;BVGU#5!^P9^V#\7(OV MG]5^ 7QFL=)U#Q-H&EG48M>L90#=0@1[/,50%8L'SN 0\75O:QD[0\T@12?3)-6 VX9'(/0U^;7_!S[=RV7[$'A1X99(G_ .$N MA&Y'*G_CUN?2OT4\''/A'2O^O.'_ - %?38C+O98&CC.:_M')6MMRVZ^=S\K MH8_VF,JX3E^!1=^_-?\ *Q:O]7M=*\O[5M1? M\%[K^XU7]K?]E7PS/=7;^'?$/B06^J:8+AUM=0C:]L4994! <%'=>>S'UKU7 MPY_PKRROVGPW]ZW:/-M?Y;GF+/\ _A*CF7)O;2_>7+O;]#](K+XL>%M2U+[' M;^)?#\]YG'D1ZC"TF?\ =#9KH*\1U/\ X)K_ !U;1VL9/@_\/XX&7:&M]'A MMYD]UEC"NI]U8$>M?)MY\3_$G_!(+]NWP+\/KWQ%K?B;]GWXO2_8M'36[MKN MY\'7V]4\N.XD.YK<,\>58G"/G[RDOQ8;+:.+YH82;YTF^622YDM79IO6VMFM M>]SMKX^KAK3Q45R-I73O:^BNFEI?2_X'Z/22")"S$*JC)). !4.FZK:ZQ;^; M:7,%U%G;OAD#KGTR*Y;]H@X_9^\=8X_XIZ_Y';_1I*^)/^#:.[EO?^">MX\T MDDK_ /"47@W.Q8_ZN'UK&CEWM,!5QO-\$HQM;?FOU\K&M7'\F-IX3E^-2=^W M+;_,_0RBD>01(68A549))P *_$+]IWXI?$[XZ?&+XC_MB>#-6U$>#/@?XPT_ M0-#TV.1EM]6L;9RMU(><;"TJ9.#G[2PR-E;Y)DLLQG*/.H)6U?64G:,?F_N2 M;,-_\'".G7&J_\$P/%T-K!-!S7A?[&O_ 79^%W[/_[*'P[\$:UX,^+$VK>%?#]GI=X]KH4; MP-+%$J,48S*2N1P2!]*^TP^78G&H/'%?#G_!#S1[O3_^"BG[7OB;]L: M7P5XM\!>,5\)^/\ X9W#ZAH9N(0]K//NC=2S8)1@T:X.UAR^ _$:GRH?$=K;E],U$ X$OR[EVGNT18#NJ\X_.56CA< M14=;2,VFGTV2U?3YG[]5RFOQ#D6!I90U5K86$XSI)_O-:DIWC%_&K2UY;OR/ MT%KX \ WF[_@X8\;P$_=\"6\@'UCA!_E7AW_ 4X_P""K,/BE\1?\ MAK#XB?$#3?%'B/XAZ*;:TL-)A M;*V9E B=L##Q>7L,8'RD,"S'FL)XR.+KQ MHTE?DDG?2UEU_&Q[Q'#&35LWS.HHK%8>=.,&IJHIS:M%Q<=-(\UV]59G M._\ !T/_ ,F->%/^QOA_]);FOT8\&_\ (H:5_P!>FVC.$^W-&KJ\()( 9D=MN>,@#C.:P_V8?^"RGP MON?A9I6D_%F_OOA1\1=#M(K+6]&\1:;SL]>Y_-D*L,+FU:>(?+&I&'*WHGR\UU?:^N MQYM_P<)_ZS]F[_LHMO\ SBK]%]3_ .0;H21LA%K9B4*TI.PKG'\9;[J@M^E&I_\ M@VX_ZY-_(UCFZ=+!83"U-)Q4VUU7-*ZOV=M;;FV5?O,7B<3#6$G%)]'RQL[= MU?KL?F+_ ,&NG_)N?Q4_[&U?_29*A_X+O?\ )]_['O\ V-2?^G#3ZO?\&PND M7>C?L[_%)+RUNK1W\6*RK/$T9(^S)R 0*K_\%[]-O-*_:O\ V6O%&/$7VO5]2BLY9K?3HEO;)V:1D4[?D1SCJ=IQFOJ6U_K;4])?^FV?-)/_5>G M_P!N_P#IQ'Z@U^7/_!S7LD\(? F*W!_MA_%4WV,CL-D(;_QXQ_E7U_J7_!6# M]G72]+DNC\6/"\XC3?Y-J\EQ-W_ -C1>?\ HN&O MM_\ :'0R? #QRJ@LQ\/WX R2?LTG2OB?_@VJTNYTC_@GS>17=M<6LO_ D] MX=DT91L>7#S@BL<(_P#A"Q/^.G^4C7%+_A9P_P#@G^<3U3_@M9^V#_PQ_P#L M&^)[RQNOLWB?QV#O7S%^S'_P %&?V.?@]_ MP3]TKX(:GXPN[C3KO0)-/US&@W9^TW%RC&YDSY9^;S';:>VU<=*]"\:Z7%_P M44_X+/6>AW=NFI_#3]FS3FN+V*>+S+34=;G 'EE6RK^6=N?1K=@:^V/^&9?A MO_T3_P $_P#@CM?_ (BNSVV"P."I83$QFYRM4?+)1LW\"=XO:.OES'+[+&8S M%U,5AY14%>FN:+=TOB:LUN]/^W3X,_X-OOVK+3QU\$O%WP?;5_[5F^&FI23: M+5]CJC_!WX[^&-* MATCP/XS4^$O%EKIUJL5O&IP-[(@"C*%)!ZM:$FOT]AF6YA62-E=' 964Y# ] M"#7%Q-"G5K1S&@K0KKF])+22^_7YG7P]*I3HRP%9WG1=O6+UB_NT^021K,N& M4,/0C-,^PP_\\8O^^!4M%?,GT(V.%85PBJHZX Q0D*1L2JJI;J0,9IU% !7+ M?%[X*>%/CWX-GT#QCH.F^(=)N.L%Y"'V'^\AZHP[,I!'K74T4I14E:6QK1KU M*-15:,G&2U33LT^Z:V/'?!?[ _PF^'GP1USX?:/X.TRS\.^);.2RU0;?,N;Y M'&"9)GR[,.JDD[2!C&*Y[_@GQ^P-;_\ !/GP%K'A;2/&>N^)_#^I7OV^VM=3 MBC7^SI",2>64[/A201U7/*YVZ\1>"O&$ M4UQ/=^&M32P0R2RR/#,+=0<$DG.T _K74D9%<'=_"R^;X3ZYH<+3=0TV:.TCW.EO M,A6%/4@'@4NC>.]%\0M,++5+&Y,"EY/+F!VJ/XO]WWZ>]<[-X*UK7_".I:1? M"VMUN0KQ3-J#WQ=@RMY;J8H_W9VX89Y#,.]:;V&MZ[8W4%]9:+9B2RD@1X;A MYVWL,=XTVKZ]2>/2@9N?;;2TMXG\VWBBN658FW +*S?= ]2>WK4,7B'3-2TR MXG2]L9[.!FBGD$JM'&5^\K'. 1W!KD7^#<\>G>'435K^:31KJUGE2XN2\+B( M88 8Z^F?:LW_ (4CJ5AX#FL;.[LUO[Q;B"[W%A!<123.Z$\9WQA^#CGE3Q@@ M Z?59_!WA#58_M:^']/O6PZEXXHY%!SAB<9 Z\GCK71)J,$EWY"S1&7S]UYE.O_$NE:!I,=Y/>V5M9S8,62WB26\C-! GVF19&,+!7*%"NT94Y5FZ9I#. MHT+4-$>T^VZ=+IGDZA-@S6Y0"XE)(P2.KYR,'G.:C@^(V@76H"UCUK2I+DR& M$1)=(7+@X*XSUSQBL#3OA[KAU.I> M(?#>NZ@-*O+G2;R<2[1;3%)/W@R-H!XW]>.M;JJ$4 8 Z5YZ/AIK&FZJ MYTB2/2('O3<9CU*26+:9"[G[.T>T%\MD!P,MD'M7H=%^@_,****0!1110 44 E44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$! end XML 7 tm2035325-3_8k_htm.xml IDEA: XBRL DOCUMENT 0001330436 2020-11-13 2020-11-13 iso4217:USD shares iso4217:USD shares 0001330436 false 8-K 2020-11-13 LIQUIDIA TECHNOLOGIES, INC. DE 001-38601 20-1926605 419 Davis Drive Suite 100 Morrisville NC 27560 919 328-4400 true false false false Common stock LQDA NASDAQ true true XML 8 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Cover
Nov. 13, 2020
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 13, 2020
Entity File Number 001-38601
Entity Registrant Name LIQUIDIA TECHNOLOGIES, INC.
Entity Central Index Key 0001330436
Entity Tax Identification Number 20-1926605
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 419 Davis Drive
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Morrisville
Entity Address, State or Province NC
Entity Address, Postal Zip Code 27560
City Area Code 919
Local Phone Number 328-4400
Written Communications true
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock
Trading Symbol LQDA
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period true
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 95 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://liquidia.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2035325-3_8k.htm lqda-20201113.xsd lqda-20201113_lab.xml lqda-20201113_pre.xml tm2035325d3_ex99-1.htm http://xbrl.sec.gov/dei/2020-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2035325-3_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "tm2035325-3_8k.htm" ] }, "labelLink": { "local": [ "lqda-20201113_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "lqda-20201113_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "lqda-20201113.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "lqda", "nsuri": "http://liquidia.com/20201113", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2035325-3_8k.htm", "contextRef": "From2020-11-13to2020-11-13", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://liquidia.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2035325-3_8k.htm", "contextRef": "From2020-11-13to2020-11-13", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-US": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://liquidia.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 15 0001104659-20-125389-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-20-125389-xbrl.zip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end